Magnetic polymeric nanobubbles with optimized core size for MRI/ultrasound bimodal molecular imaging of prostate cancer.
Yunkai ZhuYing SunWeiyong LiuWenbin GuanHuanhuan LiuYourong DuanYaqing ChenPublished in: Nanomedicine (London, England) (2020)
Aim: To design MRI/ultrasound (US) dual modality imaging probes with optimized size for prostate cancer imaging by targeting prostate-specific membrane antigen (PSMA). Materials & methods: The PSMA-targeting polypeptide-nanobubbles (PP-NBs) with core size of 400 and 700 nm were fabricated and evaluated. Results: With excellent physical property and specificity, PP-NBs of both core size could image PSMA expression in prostate cancer xenografts. Particularly, 400 nm PP-NBs generated higher PSMA-specific MRI/US dual modality contrast enhancement than 700 nm PP-NBs in correlation with histopathologic findings. Conclusion: Benefit from the smaller core size, 400 nm PP-NBs had higher permeability and specificity than 700 nm PP-NBs, hence producing better PSMA-specific MRI/US dual modality imaging.
Keyphrases
- prostate cancer
- pet ct
- magnetic resonance imaging
- contrast enhanced
- pet imaging
- photodynamic therapy
- radical prostatectomy
- high resolution
- diffusion weighted imaging
- fluorescence imaging
- computed tomography
- poor prognosis
- magnetic resonance
- positron emission tomography
- drug delivery
- physical activity
- cancer therapy
- deep learning
- mass spectrometry
- machine learning
- benign prostatic hyperplasia
- structural basis
- drug release